Hong Kong Economic Policy Green Paper 2025 Policy recommendations to inject vitality into Hong Kong's economy
Posted: Sun Feb 16, 2025 5:20 am
In 2023, Saifen Technology's market share in the domestic analytical chromatography market will be approximately 5.16%, the market share in industrial purification chromatographic media will be approximately 1.02%, and the market share in biomacromolecule chromatography media will be approximately 1.20%.
The company has more than 5,000 customers in the field of analytical chromatography worldwide, and has established good business cooperation relationships with large international pharmaceutical groups, biopharmaceutical companies and innovative drug companies including Roche, Pfizer, Eli Lilly, Gan & Lee Pharmaceuticals, Chia Tai Tianqing, Qilu Pharmaceutical, Regeneron, and Moderna, and maintains long-term and stable cooperation with international industry giants such as Agilent and Sigma-Aldrich. From January to June 2024, the company's overseas revenue accounted for 25.11%.
In addition, the company's raw materials are purchased lebanon telegram data from overseas suppliers for a relatively high proportion. During the reporting period, the amount of raw materials purchased by the company from overseas suppliers was RMB 38.0797 million, RMB 48.6876 million, RMB 41.0677 million and RMB 10.1625 million, respectively, accounting for 76.03%, 70.64%, 71.40% and 49.61% of the total raw material purchases, respectively.
Saifen Technology stated in its prospectus that the company plans to raise 800 million yuan, which will be used for 200,000 litersyear of auxiliary materials for bio-pharmaceutical separation and purification, research and development center construction projects, and to supplement working capital.
The company has more than 5,000 customers in the field of analytical chromatography worldwide, and has established good business cooperation relationships with large international pharmaceutical groups, biopharmaceutical companies and innovative drug companies including Roche, Pfizer, Eli Lilly, Gan & Lee Pharmaceuticals, Chia Tai Tianqing, Qilu Pharmaceutical, Regeneron, and Moderna, and maintains long-term and stable cooperation with international industry giants such as Agilent and Sigma-Aldrich. From January to June 2024, the company's overseas revenue accounted for 25.11%.
In addition, the company's raw materials are purchased lebanon telegram data from overseas suppliers for a relatively high proportion. During the reporting period, the amount of raw materials purchased by the company from overseas suppliers was RMB 38.0797 million, RMB 48.6876 million, RMB 41.0677 million and RMB 10.1625 million, respectively, accounting for 76.03%, 70.64%, 71.40% and 49.61% of the total raw material purchases, respectively.
Saifen Technology stated in its prospectus that the company plans to raise 800 million yuan, which will be used for 200,000 litersyear of auxiliary materials for bio-pharmaceutical separation and purification, research and development center construction projects, and to supplement working capital.